Health
Vaccine wars escalate as new antibody escape variants raise the bar – Medical Xpress
When a new mutation within the SARS-CoV-2 spike protein receptor binding domain (RBD) emerges that a particular antibody can no longer neutralyze, it is often called…
When a new mutation within the SARS-CoV-2 spike protein receptor binding domain (RBD) emerges that a particular antibody can no longer neutralyze, it is often called an escape variant. With the rapid identification of these new variants within the infected population, and also in lab-generated versions of the spike protein, an exhaustive escape variant matrix has begun to take shape. The good news is that as long as the actual antibody responses of vaccinated individuals are tested and verified,…
-
Business24 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General20 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News14 hours agoThe only person detained at Brisbane’s Palestine rally
-
Noosa News24 hours agoAusgold acquires 860ha of farmland for Katanning Gold Project